Midatech Pharma Plc | CIK:0001643918 | 3

  • Filed: 4/24/2018
  • Entity registrant name: Midatech Pharma Plc (CIK: 0001643918)
  • Generator: Novaworks Software
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1643918/000121465918002960/0001214659-18-002960-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1643918/000121465918002960/mtph-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001643918
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory

    17 Cash and cash equivalents and cash flow supporting notes

     

    Cash and cash equivalents for purposes of the consolidated statement of cash flows comprises:

     

        2017     2016     2015  
          £’000       £’000     £'000  
                           
    Cash at bank available on demand     13,204       17,608       16,175  

     

    There were no significant non-cash transactions during the year.

     

    During the year, cash inflows arose from an equity financing transaction, included within financing activities on the face of the cash flow statement.

     

        2017     2016     2015  
          £’000       £’000     £'000  
                             
    Funds raised on Public Offering     6,157       16,673       -  
    Costs of raising funds on Public Offering     (429 )     (1,105 )     -  
          5,728       15,568       -  

     

    The following changes in liabilities arose as a result of financing activities during the year:

     

       

    Non-current

    liabilities,

    borrowings

       

    Current

    liabilities,

    borrowings

      Total  
          £’000       £’000       £’000  
                             
    At 1 January 2017     -       23       23  
    Cash Flows     5,249       (12 )     5,237  
    Foreign Exchange     (42 )     -       (42 )
    At 31 December 2017     5,207       11       5,218